Advertisement
Advertisement

TXG

TXG logo

10x Genomics, Inc. Class A Common Stock

11.56
USD
-0.54
-4.50%
Feb 20, 15:59 UTC -5
Closed
exchange

After-Market

11.695

+0.14
+1.21%

10x Genomics, Inc. Class A Common Stock Profile

About

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

Info & Links

CEO

Serge Saxonov

Headquarters

6230 STONERIDGE MALL ROAD
PLEASANTON, CA 94588, UNITED STATES

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

50

Employees

410

10x Genomics, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

1.43B

Enterprise Value

1.09B

Enterprise Value/EBITDA(ttm)

-7.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.39

Price to Book(mrq)

2.06

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

67.84%

Operating Margin(ttm)

-29.90%

Profit Margin(ttm)

-30.14%

Return on Equity(ttm)

-25.40%

Return on Invested Capital(ttm)

-25.42%

Return on Assets(ttm)

-19.69%

Income Statement

Revenue(ttm)

610.78M

Revenue Per Share(ttm)

4.99

Gross Profit(ttm)

414.48M

EBITDA(ttm)3

-150.85M

Net Income Available to Common(ttm)

-182.63M

Diluted EPS(ttm)

-1.52

Share Statistics

Beta (5Y Monthly)

1.85

52-Week Change

-76.15%

S&P 500 52-Week Change

22.80%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

122.30M

Dividend Yield

0.00%

Float4

108.91M

% Held by Insiders

10.03%

% Held by Institutions

84.68%

Balance Sheet

Total Cash(mrq)

393.40M

Total Cash Per Share(mrq)

3.22

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.97%

Quick Ratio(mrq)

4.26%

Book Value Per Share(mrq)

5.81

Cash Flow

Operating Cash Flow Per Share(ytd)

0.06

Free Cash Flow(ytd)

-5.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement